Results of CO2 Laser Surgery for Early Supraglottic Cancer
Sasa Janjanin, MD, PhD (presenter) ; Drago Prgomet, MD, PhD OBJECTIVE: Supraglottic cancers are characterized with the high probability of occult neck metastasis and few reports have been published on laser microsurgery of these lesions. We present our experience with CO2 laser surgery for the management of early supraglottic carcinoma. METHOD: During a 15-year period, we performed 71 curative supraglottic laryngectomies. Thirty-two patients presented with T1 and 39 with T2 carcinoma. There were 51 patients without regional and/or distant metastases (N0 neck), and 20 patients with Nϩ neck. The evaluation of functional deglutition was performed by videofluoroscopy of the swallowing act and compared with patients after open supraglottic laryngectomy. RESULTS: All patients were treated with either neck dissection or radiotherapy, except epiglottic T1 tumors of suprahyoid localization with N0 neck. Forty patients were treated with surgery alone, and in 31 patients surgical procedure was combined with postoperative radiotherapy. The 5-year disease-free survival rate was 82%, and the 5-year overall survival rate was 71%. Aspiration was recorded in 30% of endoscopically treated patients, compared to almost 80% of patients who underwent classic supraglottic laryngectomy. Compared to open surgery, endoscopic surgery was characterized by avoidance of tracheotomy in most cases, shorter operative time, less postoperative complications, faster swallowing restitution, and lower cost of rehabilitation. CONCLUSION: Functional results outline the advantages of endoscopic surgery for early supraglottic carcinoma. An important issue is proper treatment of the neck. Endoscopic surgery is efficacious treatment for T1 and T2 supraglottic lesions. In the majority of cases, it should be combined with neck dissection or postoperative irradiation.
Retrosternal Goiter Criteria for Surgical Approach Selection
Yasser Nour, MD, FRCSEd (presenter); Mohamed Eid, MD OBJECTIVE: 1) To propose clear guidelines for preoperative planning of the appropriate surgical approach. 2) Determine factors that affect surgical approach selection. METHOD: Data were collected retrospectively from all thyroidectomies carried out by a single surgeon for retrosternal goiters over 9 years in the period between 1998 to 2007 (52 cases). RESULTS: According to the findings of computed tomography of neck and chest; 62% of cases were classified as level I (from thoracic inlet to top of aortic arch) and 38% were level II (from aortic arch to the pericardium). In 71% of cases the goiter is situated anteriorly in the mediastinum while posteriorly located goiters were found in 29% of cases. The goiter was on the left side in 57%, on right side in 31% and involving both sides in 12% of cases. Most of the right sided goiters were located posteriorly within the mediastinum. Histopathologically, the goiter was benign in 94% of patients and was resected completely through the cervical approach. The remaining 6% of cases were malignant that required an adjuvant intrathoracic approach. CONCLUSION: Cervical approach is optimum for benign retrosternal goiters reaching level I and level II whether situated anteriorly or posteriorly in the mediastinum. Malignant retrosternal goiters are better approached through intrathoracic approaches.
Role of CT in Head and Neck Cancer Following Chemoradiation
Sebastien Clavel, MSc, MD (presenter); Phuc Felix Nguyen Pan; Manon Belair, MD, MOA; Louis Guertin, MD; Apostolos Christopoulos, MSc, MD OBJECTIVE: 1) Describe the outcome of patients who are spared from neck dissection (ND) following concomitant chemoradiation (CRT) based on computed tomography (CT) response. 2) Establish CT characteristics that can predict which patients could safely avoid ND. METHOD: This retrospective study analyzed 369 patients with lymph node positive head and neck cancer treated with primary CRT from January 1998 to December 2007. Following clinical and radiological CT evaluation, patients were classified into complete response (cCR) or partial regional response (cPR). Patients outcomes were estimated using the Kaplan-Meier method and the Log-rank test. Predictive factors for pathologic response and neck recurrence were calculated using univariate analyses. RESULTS: Following CRT, 263 patients reached a cCR including 253 without ND. This was dependent on the N stage (p Ͻ 0.001). Isolated neck recurrence was noted in 4% of patients after cCR. There were no significant differences for 3-year regional control and survival rates between patients with cCR without ND and patients with cPR followed by ND (p Ͼ 0.05). Ninety-six patients reached cPR and underwent ND. Of those, 34 (35%) had residual disease at pathology. CT lymph node focal heterogeneity was well correlated with subsequent pathology results but no association with extracapsular spreading was found. Regression "equal-or-superior-to" 80% of node diameter had a negative predictive value of 100%. CONCLUSION: It is safe to observe node positive patients presenting a cCR determined by CT evaluation 6-8 weeks after CRT. This study also suggests that a lymph node regression 'equal-or-superior-to' 80% on CT following CRT may help guide clinical decisions regarding neck surgery.
Safety of Percutaneous Tracheostomy without Bronchoscopy
Kafeel Ahmed, FRCS (presenter) OBJECTIVE: Percutaneous tracheostomy now seems to be the preferred choice for elective tracheostomy and can be easily done at the bedside in the ICU. In most cases, this is performed under guidance of a bronchoscope. The aim of our study was to determine the safety of percutaneous tracheostomy without the aid of a bronchoscope. METHOD: DESIGN: Between December 2006 and December 2009, 150 critically ill patients on prolonged ventilatory support were prospectively enrolled. SETTING: Intensive care unit of a single tertiary-care referral center. SUBJECTS: One hundred and fifty patients were included (96 male, 54 female) with a mean age of 68 yrs (range, 19-105) . INTERVENTION: Bedside percutaneous tracheostomy (using the Ciaglia or the Griggs technique) without the use of bronchoscopy. The technique was modified by using surface markings, blunt dissection and finger palpation of the trachea and a technique to steady the trachea and puncture the trachea with the trocarcannula in approximate midline. MEASUREMENT: We recorded the age and sex of the patients, the airway used by the anesthetist, comorbid conditions, number of days from intubation, procedure time, coagulation study findings, difficulty during procedure, complications, and procedure-related mortality rates. RESULTS: There were 150 patients in our study. The median time from intubation to tracheostomy was 10.6 ϩ/-5.4 days. The vast majority (94%) had their tracheostomy done at bedside in the ICU. In Six patients (4%) the Griggs method was used while the rest (96%) had the Ciaglia single dilatational technique. Mean duration of the procedure was 4.1 ϩ/-2.2 minutes with a range of 2 to 14.5 minutes. Sixteen patients had deranged coagulation profile but these were corrected preoperatively. Overall complication rate was 9.3%. Of the complications 10 were per procedural, and 4 post procedural) and included bleeding (2.7%), desaturation (3.3%), difficult cannulation (1.3%), infection (0.7%), early tube dislodgement (0.7%) and paratracheal tube placement (0.7%). Of the bleeding complications, none were clinically significant and did not require surgical revision. There were no procedure-related deaths. CONCLUSION: A slightly modified technique of percutaneous dilatational tracheostomy without the use of a bronchoscope appears to be a safe and quick technique with a relatively low risk of complications. In experienced hands, this method could be considered as an acceptable alternative.
